Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 6;17(4):e0265099.
doi: 10.1371/journal.pone.0265099. eCollection 2022.

Plasma DNA and deoxyribonuclease are associated with glucose metabolism in healthy mice

Affiliations

Plasma DNA and deoxyribonuclease are associated with glucose metabolism in healthy mice

Katarína Kmeťová et al. PLoS One. .

Abstract

It is currently unknown why obesity leads in some patients to prediabetes and metabolic syndrome. Microinflammation potentially caused by extracellular DNA is supposed to be involved. The aim of this cross-sectional study in healthy mice was to analyze the association between plasma extracellular DNA and glucose metabolism. Fasting glycemia and insulin were measured in healthy adult female mice that subsequently underwent an oral glucose tolerance test. Indices of glucose metabolism and insulin sensitivity were calculated. DNA was isolated from plasma and quantified fluorometrically. Deoxyribonuclease (DNase) activity of plasma was measured using the single radial enzyme diffusion method. Fasting glycemia correlated negatively with both, extracellular DNA and DNase (r = -0.44 and r = -0.32, respectively). DNase was associated positively with the incremental area under curve (r = 0.35), while extracellular DNA correlated negatively with total area under curve of glycemia during oral glucose tolerance test (r = -0.34). Measures of insulin sensitivity were found to be associated with neither extracellular DNA, nor DNase. The hypothesis of an association of low DNase with increased fasting glucose was partially proved. Surprisingly, low extracellular DNA is associated with higher fasting glucose and lower glucose tolerance in mice. As novel therapeutic targets for prediabetes and metabolic syndrome are highly needed, this study provides novel unexpected associations within the limitations of the focus on physiological variability as it was conducted on healthy mice. The causality of these associations should be proved in further interventional experiments.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Relationship of ecDNA and DNase activity with body weight, cholesterol and triacylglycerol in the liver.
Correlations between ecDNA and body weight (a), cholesterol (c) or triacylglycerol in the liver (e). Correlations between DNase activity and body weight (b), cholesterol (d) or triacylglycerol in the liver (f). ecDNA—extracellular DNA; KU—Kunitz units.
Fig 2
Fig 2. Relationship of ecDNA and DNase activity with fasting glucose, total and incremental AUC.
Correlations between ecDNA and fasting glucose (a), total AUC (c) or incremental AUC (e). Correlations between DNase activity and fasting glucose (b), total AUC (d) or incremental AUC (f). ecDNA—extracellular DNA; AUC—area under the curve; KU—Kunitz units.
Fig 3
Fig 3. Relationship of ecDNA and DNase activity with fasting insulin, QUICKI and HOMA-IR.
Correlations between ecDNA and fasting insulin (a), QUICKI (c) or HOMA-IR (e). Correlations between DNase activity and fasting insulin (b), QUICKI (d) or HOMA-IR (f). ecDNA. ecDNA—extracellular DNA; HOMA-IR—Homeostatic Model Assessment of Insulin Resistance; QUICKI -Quantitative Insulin Sensitivity Check Index; KU—Kunitz units.

Similar articles

Cited by

References

    1. Iacobini C, Pugliese G, Blasetti Fantauzzi C, Federici M, Menini S. Metabolically healthy versus metabolically unhealthy obesity. Metabolism: clinical and experimental. 2019;92:51–60. Epub 2018/11/21. doi: 10.1016/j.metabol.2018.11.009 . - DOI - PubMed
    1. Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. The Journal of clinical investigation. 2017;127(1):1–4. Epub 2017/01/04. doi: 10.1172/JCI92035 ; PubMed Central PMCID: PMC5199709 treatment of metabolic disease. J.M. Olefsky owns stock in Catabasis Pharmaceuticals and receives consulting income from Cymabay Inc., Second Genome, and AntriaBio. - DOI - PMC - PubMed
    1. Aguilar-Salinas CA, Viveros-Ruiz T. Recent advances in managing/understanding the metabolic syndrome. F1000Research. 2019;8. Epub 2019/04/20. doi: 10.12688/f1000research.17047.1 ; PubMed Central PMCID: PMC6449786. - DOI - PMC - PubMed
    1. Pisetsky DS. The origin and properties of extracellular DNA: from PAMP to DAMP. Clinical immunology (Orlando, Fla). 2012;144(1):32–40. Epub 2012/06/05. doi: 10.1016/j.clim.2012.04.006 ; PubMed Central PMCID: PMC3724456. - DOI - PMC - PubMed
    1. Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, et al.. Detection of circulating tumor DNA in early- and late-stage human malignancies. Science translational medicine. 2014;6(224):224ra24. Epub 2014/02/21. doi: 10.1126/scitranslmed.3007094 ; PubMed Central PMCID: PMC4017867. - DOI - PMC - PubMed

Publication types